Transgene SA
PAR:TNG

Watchlist Manager
Transgene SA Logo
Transgene SA
PAR:TNG
Watchlist
Price: 0.912 EUR -0.44% Market Closed
Market Cap: 121.1m EUR

Wall Street
Price Targets

TNG Price Targets Summary
Transgene SA

Wall Street analysts forecast TNG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNG is 1.632 EUR with a low forecast of 1.111 EUR and a high forecast of 2.1 EUR.

Lowest
Price Target
1.111 EUR
22% Upside
Average
Price Target
1.632 EUR
79% Upside
Highest
Price Target
2.1 EUR
130% Upside
Transgene SA Competitors:
Price Targets
VCEL
Vericel Corp
49% Upside
ATX
Amplia Therapeutics Ltd
243% Upside
251120
Bio-FD&C Co Ltd
18% Upside
6855
Ascentage Pharma Group International
78% Upside
UTHR
United Therapeutics Corp
8% Upside
688278
Xiamen Amoytop Biotech Co Ltd
20% Upside
CRVO
Diffusion Pharmaceuticals Inc
160% Upside
ALEC
Alector Inc
69% Upside

Revenue
Forecast

Revenue Estimate
Transgene SA

For the last 13 years the compound annual growth rate for Transgene SA's revenue is -6%. The projected CAGR for the next 3 years is 14%.

-6%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Transgene SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Transgene SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-56%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNG's stock price target?
Price Target
1.632 EUR

According to Wall Street analysts, the average 1-year price target for TNG is 1.632 EUR with a low forecast of 1.111 EUR and a high forecast of 2.1 EUR.

What is Transgene SA's Revenue forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for Transgene SA's revenue is -6%. The projected CAGR for the next 3 years is 14%.

Back to Top